Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010, Article ID 149591, 4 pages
http://dx.doi.org/10.1155/2010/149591
Case Report

Prolonged Use of Ertapenem to Treat Infected Diabetic Foot Ulcers

Department of Microbiology, North Middlesex Hospital, Stirling Way, Edmonton, London N18 1QX, UK

Received 24 July 2010; Revised 12 September 2010; Accepted 13 September 2010

Academic Editor: Anthony W. Chow

Copyright © 2010 Ashwin Algudkar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. A. Cunha, “Antibiotic selection for diabetic foot infections: a review,” Journal of Foot and Ankle Surgery, vol. 39, no. 4, pp. 253–257, 2000. View at Google Scholar · View at Scopus
  2. O. Burkhardt, H. Derendorf, and T. Welte, “Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice,” Expert Opinion on Pharmacotherapy, vol. 8, no. 2, pp. 237–256, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. G. M. Keating and C. M. Perry, “Ertapenem: a review of its use in the treatment of bacterial infections,” Drugs, vol. 65, no. 15, pp. 2151–2178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. H. M. Wexler, “In vitro activity of ertapenem: review of recent studies,” Journal of Antimicrobial Chemotherapy, vol. 53, S2, pp. ii11–ii21, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. L. J. Wheat, S. D. Allen, M. Henry et al., “Diabetic foot infections. Bacteriologic analysis,” Archives of Internal Medicine, vol. 146, no. 10, pp. 1935–1940, 1986. View at Google Scholar · View at Scopus
  6. P. R. Cavanagh, B. A. Lipsky, A. W. Bradbury, and G. Botek, “Treatment for diabetic foot ulcers,” Lancet, vol. 366, no. 9498, pp. 1725–1735, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. D. M. Citron, E. J. C. Goldstein, C. V. Merriam, B. A. Lipsky, and M. A. Abramson, “Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents,” Journal of Clinical Microbiology, vol. 45, no. 9, pp. 2819–2828, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. B. A. Lipsky, D. G. Armstrong, D. M. Citron, A. D. Tice, D. E. Morgenstern, and M. A. Abramson, “Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial,” Lancet, vol. 366, no. 9498, pp. 1695–1703, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. http://emc.medicines.org.uk/document.aspx?documentId=10421.